{N}-methyl-1-phenyl-bicyclo[1.1.1]pentan-3-amine hydrobromide, 95.0%, 250mg

2,4,5,6-Tetrachloropyrimidine, 96.0%, 500g

7-Bromo-3-iodo-1H-pyrazolo[4,3-c]pyridine, 95+%, 5g

4-((4-METHYLPIPERAZIN-1-YL)METHYL)BENZOYL CHLORIDE, 95.0%, 250mg

Methyl 5-chloro-2-(methylamino)benzoate, 95.0%, 100mg

3-Bromo-2,3,4,5-tetrahydro-2H-benzo[b]azepin-2-one, 95.0%, 500g

DBD-F [=4-(N,N-Dimethylaminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole] [for HPLC Labeling]>98.0%(HPLC)100mg

3-Bromo-2-hydrazinyl-5-(trifluoromethyl)pyridine, 95.0%, 5g

Benzo[h]quinazolin-2-amine, 6-(2-fluorophenyl)-5,6-dihydro-N-[3-[2-[(2-methoxyethyl)amino]ethyl]phenyl]-, (6R)-, 99%, 100mg

3,3,5-Trimethylcyclohexanone, 95.0%, 25g

Glycochenodeoxycholic acid, 98%, 1g

Tert-butyl 4-(3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine-1-carboxylate, 96%, 250mg

5,7-Dichloropyrazolo[1,5-a]pyrimidine, 98.0%, 5g